Gelatinase B deficiency protects against endotoxin shock

European Journal of Immunology

Volumn 32, Issue 8, 2002, Pages 2163-2171

  Dubois, Bénédicte ^a   Starckx, Sofie ^a   Pagenstecher, Axel ^b   Van Den Oord, Joost ^c   Arnold, Bernd ^d   Opdenakker, Ghislain ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Inflammation; Lipopolysaccharide; Matrix metalloproteinase; Sepsis; Tissue inhibitor of MMP

Indexed keywords

ENDOTOXIN; GELATINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDOTOXEMIA; ENZYME DEFICIENCY; ENZYME INHIBITION; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPTIC SHOCK; WILD TYPE;

ANIMALS; GENE EXPRESSION REGULATION; LEUKOCYTES; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; SHOCK, SEPTIC; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0036686258     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200208)32:8<2163::AID-IMMU2163>3.0.CO;2-Q     Document Type: Article

References (41)

1. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy
2. The pathogenesis of sepsis
3. Bacterial endotoxins
4. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock
5. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes
6. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection
7. Interferon γ receptor deficient mice are resistant to endotoxic shock
8. Mechanisms of disease: Pathogenetic mechanisms of septic shock
9. Bacterial lipopolysaccharide potentiates gamma interferon-induced cytotoxicity for normal mouse and rat fibroblasts
10. Proteinases and their inhibitors in septicemia - Basic concepts and clinical implications
11. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: Evidence for neutrophils as mediators in fatal sepsis
12. Matrix metalloproteinase-9 concentrations in critically ill patients
13. Sepsis begins at the interface of pathogen and host
14. Ethanol ingestion increases activation of matrix metalloproteinases in rat lungs during acute endotoxemia
15. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation
16. Diethyldithiocarbamate prolongs survival of mice in a lipopolysaccharide-induced endotoxic shock model: Evidence for multiple mechanisms
17. Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock: Effect of fiber-immobilized polymyxin B treatment
18. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8
19. Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis
20. Induction of gelatinase B and MCP-2 in baboons during sublethal and lethal bacteraemia
21. Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice
22. Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators
23. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions
24. Gelatinase B functions as regulator and effector in leukocyte biology
25. Gelatinase B: A tuner and amplifier of immune functions
26. In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse
27. A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality
28. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
29. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid
30. Production and characterization of recombinant active mouse gelatinase B from eukaryotic cells and in vivo effects after intravenous administration
31. The molecular basis of leukocytosis
32. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9)
33. Interleukin-8 in sepsis: Relation to shock and inflammatory mediators
34. Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock
35. IL-8 in septic shock, endotoxemia, and after IL-1 administration
36. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact
37. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
38. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)
39. Toll-like receptors: How they work and what they do
40. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopoly-saccharide: Evidence for TLR4 as the Lps gene product
41. The gene family encoding the mouse ribosomal protein L32 contains a uniquely expressed intron-containing gene and an unmutated processed gene